메뉴 건너뛰기




Volumn 141, Issue 2-3, 2012, Pages 168-172

Early symptom response to antipsychotic medication as a marker of subsequent symptom change: An eighteen-month follow-up study of recent episode schizophrenia

Author keywords

Clinical trial; Delayed response; Early response; PANSS; Recent episode; Schizophrenia; Treatment response

Indexed keywords

HALOPERIDOL; OLANZAPINE;

EID: 84866950525     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.08.030     Document Type: Article
Times cited : (22)

References (16)
  • 1
    • 0345167930 scopus 로고    scopus 로고
    • Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected
    • Agid O., Kapur S., Arenovich T., Zipursky R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch. Gen. Psychiatry 2003, 60(12):1228-1235.
    • (2003) Arch. Gen. Psychiatry , vol.60 , Issue.12 , pp. 1228-1235
    • Agid, O.1    Kapur, S.2    Arenovich, T.3    Zipursky, R.B.4
  • 2
    • 54249144638 scopus 로고    scopus 로고
    • Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia
    • Ascher-Svanum H., Nyhuis A.W., Faries D.E., Kinon B.J., Baker R.W., Shekhar A. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr. Bull. 2008, 34(6):1163-1171.
    • (2008) Schizophr. Bull. , vol.34 , Issue.6 , pp. 1163-1171
    • Ascher-Svanum, H.1    Nyhuis, A.W.2    Faries, D.E.3    Kinon, B.J.4    Baker, R.W.5    Shekhar, A.6
  • 4
    • 0348047433 scopus 로고    scopus 로고
    • First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
    • Green A.I., Tohen M.F., Hamer R.M., Strakowski S.M., Lieberman J.A., Glick I. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr. Res. 2004, 66(2-3):125-135.
    • (2004) Schizophr. Res. , vol.66 , Issue.2-3 , pp. 125-135
    • Green, A.I.1    Tohen, M.F.2    Hamer, R.M.3    Strakowski, S.M.4    Lieberman, J.A.5    Glick, I.6
  • 5
    • 0024760391 scopus 로고
    • The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation
    • Kay S.R., Opler L.A., Lindenmayer J.P. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br. J. Psychiatry Suppl. 1989, 7:59-67.
    • (1989) Br. J. Psychiatry Suppl. , vol.7 , pp. 59-67
    • Kay, S.R.1    Opler, L.A.2    Lindenmayer, J.P.3
  • 6
    • 46249092841 scopus 로고    scopus 로고
    • Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia
    • Kinon B.J., Chen L., Ascher-Svanum H., Stauffer V.L., Kollack-Walker S., Sniadecki J.L. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr. Res. 2008, 102(1-3):230-240.
    • (2008) Schizophr. Res. , vol.102 , Issue.1-3 , pp. 230-240
    • Kinon, B.J.1    Chen, L.2    Ascher-Svanum, H.3    Stauffer, V.L.4    Kollack-Walker, S.5    Sniadecki, J.L.6
  • 7
    • 72449167382 scopus 로고    scopus 로고
    • Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia
    • Kinon B.J., Chen L., Ascher-Svanum H., Stauffer V.L., Kollack-Walker S., Zhou W. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology 2010, 35(2):581-590.
    • (2010) Neuropsychopharmacology , vol.35 , Issue.2 , pp. 581-590
    • Kinon, B.J.1    Chen, L.2    Ascher-Svanum, H.3    Stauffer, V.L.4    Kollack-Walker, S.5    Zhou, W.6
  • 8
    • 20444369114 scopus 로고    scopus 로고
    • Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended
    • Leucht S., Busch R., Hamann J., Kissling W., Kane J.M. Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol. Psychiatry 2005, 57(12):1543-1549.
    • (2005) Biol. Psychiatry , vol.57 , Issue.12 , pp. 1543-1549
    • Leucht, S.1    Busch, R.2    Hamann, J.3    Kissling, W.4    Kane, J.M.5
  • 9
    • 42749091544 scopus 로고    scopus 로고
    • Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study
    • Leucht S., Shamsi S.A., Busch R., Kissling W., Kane J.M. Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study. Schizophr. Res. 2008, 101(1-3):312-319.
    • (2008) Schizophr. Res. , vol.101 , Issue.1-3 , pp. 312-319
    • Leucht, S.1    Shamsi, S.A.2    Busch, R.3    Kissling, W.4    Kane, J.M.5
  • 10
    • 64349118890 scopus 로고    scopus 로고
    • Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
    • Leucht S., Davis J.M., Engel R.R., Kissling W., Kane J.M. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation. Acta Psychiatr. Scand. Suppl. 2009, 438:7-14.
    • (2009) Acta Psychiatr. Scand. Suppl. , vol.438 , pp. 7-14
    • Leucht, S.1    Davis, J.M.2    Engel, R.R.3    Kissling, W.4    Kane, J.M.5
  • 11
    • 0042882529 scopus 로고    scopus 로고
    • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol
    • Lieberman J.A., Tollefson G., Tohen M., Green A.I., Gur R.E., Kahn R. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am. J. Psychiatry 2003, 160(8):1396-1404.
    • (2003) Am. J. Psychiatry , vol.160 , Issue.8 , pp. 1396-1404
    • Lieberman, J.A.1    Tollefson, G.2    Tohen, M.3    Green, A.I.4    Gur, R.E.5    Kahn, R.6
  • 13
    • 0034934721 scopus 로고    scopus 로고
    • Accounting for dropout bias using mixed-effects models
    • Mallinckrodt C.H., Clark W.S., David S.R. Accounting for dropout bias using mixed-effects models. J. Biopharm. Stat. 2001, 11(1-2):9-21.
    • (2001) J. Biopharm. Stat. , vol.11 , Issue.1-2 , pp. 9-21
    • Mallinckrodt, C.H.1    Clark, W.S.2    David, S.R.3
  • 14
    • 0035739468 scopus 로고    scopus 로고
    • Type I error rates from mixed effects model repeated measures versus fixed effects anova with missing values imputed via last observation carried forward
    • Mallinckrodt C.H., Clark W.S., David S.R. Type I error rates from mixed effects model repeated measures versus fixed effects anova with missing values imputed via last observation carried forward. Drug Inf. J. 2001, 35(4):1215-1225.
    • (2001) Drug Inf. J. , vol.35 , Issue.4 , pp. 1215-1225
    • Mallinckrodt, C.H.1    Clark, W.S.2    David, S.R.3
  • 15
    • 68149132485 scopus 로고    scopus 로고
    • Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features
    • Rabinowitz J., Levine S.Z., Barkai O., Davidov O. Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features. Schizophr. Bull. 2009, 35(4):775-788.
    • (2009) Schizophr. Bull. , vol.35 , Issue.4 , pp. 775-788
    • Rabinowitz, J.1    Levine, S.Z.2    Barkai, O.3    Davidov, O.4
  • 16
    • 79953079202 scopus 로고    scopus 로고
    • Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
    • Stauffer V.L., Case M., Kinon B.J., Conley R., Ascher-Svanum H., Kollack-Walker S. Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Res. 2011, 187(1-2):42-48.
    • (2011) Psychiatry Res. , vol.187 , Issue.1-2 , pp. 42-48
    • Stauffer, V.L.1    Case, M.2    Kinon, B.J.3    Conley, R.4    Ascher-Svanum, H.5    Kollack-Walker, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.